title: [The efficacy of treating peptic ulcer patients with trichopol and dalargin].
abstract: A study of 90 patients with endoscopically proved duodenal ulcer revealed that dalargin and trichopol+dalargin treatment resulted in early scarring of the ulcer and control of gastroesophageal and duodenogastric reflux in the majority of patients. Gastroduodenitis symptoms were not eliminated in a half of all patients. It was shown that persistent manifestations of gastroduodenitis remained in patients with a pronounced pyloric helicobacteriosis and a high titer of antibodies to cells of the gastric mucosa.
authors.forename: N V
authors.initials: NV
authors.lastname: Lukash
authors.forename: N P
authors.initials: NP
authors.lastname: Buglak
authors.forename: O N
authors.initials: ON
authors.lastname: Kriuchkova
authors.forename: S N
authors.initials: SN
authors.lastname: Lukash
authors.forename: S I
authors.initials: SI
authors.lastname: Maloshenko
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy*; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; D016308:Enkephalin, Leucine-2-Alanine; C002791:bismuth tripotassium dicitrate; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
vernacular_title: Effektivnost' lecheniia bol'nykh iazvennoĭ bolezn'iu trikhopolom i dalarginom.